Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Matrix Metalloproteinase (MMP) in Heart Failure

This study has been completed.
Sponsor:
Information provided by:
Tottori University Hospital
ClinicalTrials.gov Identifier:
NCT00663494
First received: April 18, 2008
Last updated: July 20, 2011
Last verified: April 2008
  Purpose

The purpose of this study is to evaluate the production of MMP in failing hearts.


Condition
Chronic Stable Heart Failure

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: MMP is Produced in Failing Hearts

Resource links provided by NLM:


Further study details as provided by Tottori University Hospital:

Primary Outcome Measures:
  • MMPs level of coronary sinus

Estimated Enrollment: 22
Study Start Date: February 2003
Study Completion Date: July 2006
Detailed Description:

Myocardial fibrosis is observed in failing hearts and parallel to the progression of chronic heart failure (CHF) and myocardial remodeling. Matrix metalloproteinases (MMPs) are considered markers of fibrosis. Recently, circulating MMPs can be measured and are elevated in patients with CHF. However, MMPs it is still unclear whether MMPs are produced in failing hearts. Thus, the purpose of this study is to evaluate the production of MMP in failing hearts.

  Eligibility

Genders Eligible for Study:   Both
Sampling Method:   Non-Probability Sample
Study Population

chronic heart failure

Criteria

Inclusion Criteria:

  • chronic stable heart failure
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Kazuhide Ogino, Tottori University Hospital
ClinicalTrials.gov Identifier: NCT00663494     History of Changes
Other Study ID Numbers: #244
Study First Received: April 18, 2008
Last Updated: July 20, 2011
Health Authority: Japan: Ministry of Health, Labor and Welfare

Keywords provided by Tottori University Hospital:
heart failure
MMP
coronary sinus

Additional relevant MeSH terms:
Heart Failure
Cardiovascular Diseases
Heart Diseases

ClinicalTrials.gov processed this record on November 24, 2014